Home/Filings/4/0001562180-24-003948
4//SEC Filing

Burke Steven Keith 4

Accession 0001562180-24-003948

CIK 0001517022other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 5:27 PM ET

Size

4.7 KB

Accession

0001562180-24-003948

Insider Transaction Report

Form 4
Period: 2023-08-25
Burke Steven Keith
SVP, Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2023-08-25$1.15/sh27,000$31,050668,840 total

Issuer

Akebia Therapeutics, Inc.

CIK 0001517022

Entity typeother

Related Parties

1
  • filerCIK 0001619834

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 5:27 PM ET
Size
4.7 KB